# Tenaci-T Therapeutics LLC

Canonical: https://abierto.us/vendors/tenaci-t-therapeutics-llc-mtrtyvl8n717

- UEI: MTRTYVL8N717
- CAGE: 01U66
- Location: Missouri City, TX
- Awards in window: 1 (2 transactions), $297,621 obligated, September 16, 2025 to September 14, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, $297,621

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $297,621

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N91025C00012 (definitive contract): $297,621, NIH NCI. FY2025 SBIR Concept Clearance Award for Topic Development of Therapeutic or Preventative Technologies for Treatment or Prevention of Pediatric Cancers And/Or Rare Cancers.. https://www.usaspending.gov/award/CONT_AWD_75N91025C00012_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/tenaci-t-therapeutics-llc-mtrtyvl8n717.